SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-083645
Filing Date
2022-07-28
Accepted
2022-07-28 16:03:55
Documents
2
Period of Report
2022-07-26

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2222080-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2222080-1_4seq1.xml 4 6433
2 EXHIBIT 24 tm2222080d1_ex24.htm EX-24 6224
  Complete submission text file 0001104659-22-083645.txt   14166
Mailing Address 200 BERKELEY ST. FL 19 BOSTON MA 02116
Business Address 200 BERKELEY ST. FL 19 BOSTON MA 02116 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Issuer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEUROBO PHARMACEUTICALS, INC. 177 HUNTINGTON AVENUE, SUITE 1700 BOSTON MA 02115
Business Address
Kim Na Yeon (Reporting) CIK: 0001794779 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37809 | Film No.: 221115208